GO:0043228 | non-membrane-bounded organelle | 21.13% (41/194) | 4.57 | 0.0 | 0.0 |
GO:0043232 | intracellular non-membrane-bounded organelle | 21.13% (41/194) | 4.57 | 0.0 | 0.0 |
GO:0006412 | translation | 19.07% (37/194) | 4.76 | 0.0 | 0.0 |
GO:0003735 | structural constituent of ribosome | 19.07% (37/194) | 4.73 | 0.0 | 0.0 |
GO:0043043 | peptide biosynthetic process | 19.07% (37/194) | 4.7 | 0.0 | 0.0 |
GO:0005840 | ribosome | 18.56% (36/194) | 4.77 | 0.0 | 0.0 |
GO:0006518 | peptide metabolic process | 19.07% (37/194) | 4.64 | 0.0 | 0.0 |
GO:0043604 | amide biosynthetic process | 19.07% (37/194) | 4.6 | 0.0 | 0.0 |
GO:0043603 | cellular amide metabolic process | 19.07% (37/194) | 4.48 | 0.0 | 0.0 |
GO:0019538 | protein metabolic process | 29.38% (57/194) | 3.16 | 0.0 | 0.0 |
GO:0005198 | structural molecule activity | 19.07% (37/194) | 4.18 | 0.0 | 0.0 |
GO:1901564 | organonitrogen compound metabolic process | 30.41% (59/194) | 2.76 | 0.0 | 0.0 |
GO:1901566 | organonitrogen compound biosynthetic process | 19.07% (37/194) | 3.88 | 0.0 | 0.0 |
GO:0043229 | intracellular organelle | 21.65% (42/194) | 3.49 | 0.0 | 0.0 |
GO:0043226 | organelle | 21.65% (42/194) | 3.49 | 0.0 | 0.0 |
GO:0034645 | cellular macromolecule biosynthetic process | 19.59% (38/194) | 3.65 | 0.0 | 0.0 |
GO:0044267 | cellular protein metabolic process | 23.2% (45/194) | 3.15 | 0.0 | 0.0 |
GO:0009059 | macromolecule biosynthetic process | 19.59% (38/194) | 3.49 | 0.0 | 0.0 |
GO:0043170 | macromolecule metabolic process | 31.96% (62/194) | 2.43 | 0.0 | 0.0 |
GO:0044271 | cellular nitrogen compound biosynthetic process | 19.59% (38/194) | 3.36 | 0.0 | 0.0 |
GO:0044260 | cellular macromolecule metabolic process | 26.8% (52/194) | 2.63 | 0.0 | 0.0 |
GO:0006807 | nitrogen compound metabolic process | 32.47% (63/194) | 2.27 | 0.0 | 0.0 |
GO:0005575 | cellular_component | 32.99% (64/194) | 2.13 | 0.0 | 0.0 |
GO:0044249 | cellular biosynthetic process | 20.1% (39/194) | 2.89 | 0.0 | 0.0 |
GO:1901576 | organic substance biosynthetic process | 20.1% (39/194) | 2.82 | 0.0 | 0.0 |
GO:0009058 | biosynthetic process | 20.62% (40/194) | 2.7 | 0.0 | 0.0 |
GO:0044238 | primary metabolic process | 32.47% (63/194) | 1.93 | 0.0 | 0.0 |
GO:0034641 | cellular nitrogen compound metabolic process | 21.65% (42/194) | 2.53 | 0.0 | 0.0 |
GO:0071704 | organic substance metabolic process | 32.47% (63/194) | 1.83 | 0.0 | 0.0 |
GO:0044237 | cellular metabolic process | 28.87% (56/194) | 1.99 | 0.0 | 0.0 |
GO:0009987 | cellular process | 36.08% (70/194) | 1.65 | 0.0 | 0.0 |
GO:0110165 | cellular anatomical entity | 23.71% (46/194) | 1.99 | 0.0 | 0.0 |
GO:0005839 | proteasome core complex | 5.15% (10/194) | 5.62 | 0.0 | 0.0 |
GO:0004298 | threonine-type endopeptidase activity | 5.15% (10/194) | 5.62 | 0.0 | 0.0 |
GO:0070003 | threonine-type peptidase activity | 5.15% (10/194) | 5.62 | 0.0 | 0.0 |
GO:0051603 | proteolysis involved in cellular protein catabolic process | 6.19% (12/194) | 4.83 | 0.0 | 0.0 |
GO:0003674 | molecular_function | 55.15% (107/194) | 0.93 | 0.0 | 0.0 |
GO:0008150 | biological_process | 41.75% (81/194) | 1.18 | 0.0 | 0.0 |
GO:0032991 | protein-containing complex | 12.37% (24/194) | 2.71 | 0.0 | 0.0 |
GO:0008152 | metabolic process | 32.99% (64/194) | 1.33 | 0.0 | 0.0 |
GO:0004175 | endopeptidase activity | 5.15% (10/194) | 3.47 | 0.0 | 0.0 |
GO:0006508 | proteolysis | 6.19% (12/194) | 2.87 | 0.0 | 1e-06 |
GO:0070011 | peptidase activity, acting on L-amino acid peptides | 6.19% (12/194) | 2.78 | 0.0 | 1e-06 |
GO:0008233 | peptidase activity | 6.19% (12/194) | 2.74 | 0.0 | 2e-06 |
GO:0043632 | modification-dependent macromolecule catabolic process | 3.09% (6/194) | 4.3 | 0.0 | 3e-06 |
GO:0006511 | ubiquitin-dependent protein catabolic process | 3.09% (6/194) | 4.3 | 0.0 | 3e-06 |
GO:0019941 | modification-dependent protein catabolic process | 3.09% (6/194) | 4.3 | 0.0 | 3e-06 |
GO:0019773 | proteasome core complex, alpha-subunit complex | 2.06% (4/194) | 5.52 | 1e-06 | 5e-06 |
GO:0035639 | purine ribonucleoside triphosphate binding | 12.89% (25/194) | 1.6 | 1e-06 | 5e-06 |
GO:0032555 | purine ribonucleotide binding | 12.89% (25/194) | 1.59 | 1e-06 | 6e-06 |
GO:0032553 | ribonucleotide binding | 12.89% (25/194) | 1.56 | 1e-06 | 8e-06 |
GO:0097367 | carbohydrate derivative binding | 12.89% (25/194) | 1.56 | 1e-06 | 8e-06 |
GO:0017076 | purine nucleotide binding | 12.89% (25/194) | 1.55 | 1e-06 | 9e-06 |
GO:0005524 | ATP binding | 10.82% (21/194) | 1.67 | 3e-06 | 1.8e-05 |
GO:0032559 | adenyl ribonucleotide binding | 10.82% (21/194) | 1.66 | 3e-06 | 2e-05 |
GO:0030554 | adenyl nucleotide binding | 10.82% (21/194) | 1.66 | 3e-06 | 2e-05 |
GO:0044265 | cellular macromolecule catabolic process | 3.09% (6/194) | 3.65 | 7e-06 | 4.3e-05 |
GO:0008144 | drug binding | 10.82% (21/194) | 1.57 | 8e-06 | 5.1e-05 |
GO:0031334 | positive regulation of protein-containing complex assembly | 1.55% (3/194) | 5.69 | 1.2e-05 | 5.9e-05 |
GO:0005885 | Arp2/3 protein complex | 1.55% (3/194) | 5.69 | 1.2e-05 | 5.9e-05 |
GO:0097435 | supramolecular fiber organization | 1.55% (3/194) | 5.69 | 1.2e-05 | 5.9e-05 |
GO:1902905 | positive regulation of supramolecular fiber organization | 1.55% (3/194) | 5.69 | 1.2e-05 | 5.9e-05 |
GO:0051495 | positive regulation of cytoskeleton organization | 1.55% (3/194) | 5.69 | 1.2e-05 | 5.9e-05 |
GO:0045010 | actin nucleation | 1.55% (3/194) | 5.69 | 1.2e-05 | 5.9e-05 |
GO:0044089 | positive regulation of cellular component biogenesis | 1.55% (3/194) | 5.69 | 1.2e-05 | 5.9e-05 |
GO:0034314 | Arp2/3 complex-mediated actin nucleation | 1.55% (3/194) | 5.69 | 1.2e-05 | 5.9e-05 |
GO:0032273 | positive regulation of protein polymerization | 1.55% (3/194) | 5.69 | 1.2e-05 | 5.9e-05 |
GO:0030838 | positive regulation of actin filament polymerization | 1.55% (3/194) | 5.69 | 1.2e-05 | 5.9e-05 |
GO:0010638 | positive regulation of organelle organization | 1.55% (3/194) | 5.69 | 1.2e-05 | 5.9e-05 |
GO:0007015 | actin filament organization | 1.55% (3/194) | 5.69 | 1.2e-05 | 5.9e-05 |
GO:0140096 | catalytic activity, acting on a protein | 8.76% (17/194) | 1.77 | 1.1e-05 | 6.4e-05 |
GO:0003723 | RNA binding | 4.64% (9/194) | 2.68 | 1.1e-05 | 6.7e-05 |
GO:0009057 | macromolecule catabolic process | 3.09% (6/194) | 3.4 | 1.9e-05 | 9.2e-05 |
GO:0051130 | positive regulation of cellular component organization | 1.55% (3/194) | 5.37 | 3e-05 | 0.000139 |
GO:0005856 | cytoskeleton | 1.55% (3/194) | 5.37 | 3e-05 | 0.000139 |
GO:0051493 | regulation of cytoskeleton organization | 1.55% (3/194) | 5.11 | 5.8e-05 | 0.000222 |
GO:0044087 | regulation of cellular component biogenesis | 1.55% (3/194) | 5.11 | 5.8e-05 | 0.000222 |
GO:0008064 | regulation of actin polymerization or depolymerization | 1.55% (3/194) | 5.11 | 5.8e-05 | 0.000222 |
GO:0043254 | regulation of protein-containing complex assembly | 1.55% (3/194) | 5.11 | 5.8e-05 | 0.000222 |
GO:0019843 | rRNA binding | 1.55% (3/194) | 5.11 | 5.8e-05 | 0.000222 |
GO:0048522 | positive regulation of cellular process | 1.55% (3/194) | 5.11 | 5.8e-05 | 0.000222 |
GO:0048518 | positive regulation of biological process | 1.55% (3/194) | 5.11 | 5.8e-05 | 0.000222 |
GO:1902903 | regulation of supramolecular fiber organization | 1.55% (3/194) | 5.11 | 5.8e-05 | 0.000222 |
GO:0032970 | regulation of actin filament-based process | 1.55% (3/194) | 5.11 | 5.8e-05 | 0.000222 |
GO:0090066 | regulation of anatomical structure size | 1.55% (3/194) | 5.11 | 5.8e-05 | 0.000222 |
GO:0030833 | regulation of actin filament polymerization | 1.55% (3/194) | 5.11 | 5.8e-05 | 0.000222 |
GO:0032535 | regulation of cellular component size | 1.55% (3/194) | 5.11 | 5.8e-05 | 0.000222 |
GO:0110053 | regulation of actin filament organization | 1.55% (3/194) | 5.11 | 5.8e-05 | 0.000222 |
GO:0032271 | regulation of protein polymerization | 1.55% (3/194) | 5.11 | 5.8e-05 | 0.000222 |
GO:0032956 | regulation of actin cytoskeleton organization | 1.55% (3/194) | 5.11 | 5.8e-05 | 0.000222 |
GO:0030832 | regulation of actin filament length | 1.55% (3/194) | 5.11 | 5.8e-05 | 0.000222 |
GO:0000166 | nucleotide binding | 12.89% (25/194) | 1.24 | 5.8e-05 | 0.000266 |
GO:1901265 | nucleoside phosphate binding | 12.89% (25/194) | 1.24 | 5.8e-05 | 0.000266 |
GO:0043168 | anion binding | 12.89% (25/194) | 1.19 | 9.1e-05 | 0.000343 |
GO:0036094 | small molecule binding | 12.89% (25/194) | 1.16 | 0.000132 | 0.000492 |
GO:1901363 | heterocyclic compound binding | 18.04% (35/194) | 0.93 | 0.000144 | 0.000524 |
GO:0097159 | organic cyclic compound binding | 18.04% (35/194) | 0.93 | 0.000144 | 0.000524 |
GO:0007062 | sister chromatid cohesion | 1.03% (2/194) | 6.11 | 0.00021 | 0.000743 |
GO:0007064 | mitotic sister chromatid cohesion | 1.03% (2/194) | 6.11 | 0.00021 | 0.000743 |
GO:0031390 | Ctf18 RFC-like complex | 1.03% (2/194) | 6.11 | 0.00021 | 0.000743 |
GO:0033043 | regulation of organelle organization | 1.55% (3/194) | 4.52 | 0.000238 | 0.000833 |
GO:0044248 | cellular catabolic process | 3.09% (6/194) | 2.71 | 0.000297 | 0.00103 |
GO:0051128 | regulation of cellular component organization | 1.55% (3/194) | 4.37 | 0.000336 | 0.001154 |
GO:1901575 | organic substance catabolic process | 3.09% (6/194) | 2.58 | 0.000487 | 0.001659 |
GO:0015629 | actin cytoskeleton | 1.03% (2/194) | 5.52 | 0.000624 | 0.002103 |
GO:0009056 | catabolic process | 3.09% (6/194) | 2.48 | 0.000709 | 0.002369 |
GO:0022402 | cell cycle process | 1.55% (3/194) | 3.88 | 0.000976 | 0.003229 |
GO:0005737 | cytoplasm | 2.06% (4/194) | 2.94 | 0.001767 | 0.005793 |
GO:0016787 | hydrolase activity | 10.31% (20/194) | 1.03 | 0.001881 | 0.006108 |
GO:0005819 | spindle | 1.03% (2/194) | 4.3 | 0.004201 | 0.013046 |
GO:0072686 | mitotic spindle | 1.03% (2/194) | 4.3 | 0.004201 | 0.013046 |
GO:0006888 | endoplasmic reticulum to Golgi vesicle-mediated transport | 1.03% (2/194) | 4.3 | 0.004201 | 0.013046 |
GO:1903047 | mitotic cell cycle process | 1.03% (2/194) | 4.3 | 0.004201 | 0.013046 |
GO:0004843 | thiol-dependent ubiquitin-specific protease activity | 1.03% (2/194) | 4.3 | 0.004201 | 0.013046 |
GO:0042729 | DASH complex | 1.03% (2/194) | 4.11 | 0.005548 | 0.016788 |
GO:0000942 | condensed nuclear chromosome outer kinetochore | 1.03% (2/194) | 4.11 | 0.005548 | 0.016788 |
GO:0000940 | condensed chromosome outer kinetochore | 1.03% (2/194) | 4.11 | 0.005548 | 0.016788 |
GO:0043167 | ion binding | 13.92% (27/194) | 0.7 | 0.008492 | 0.025476 |
GO:0005488 | binding | 24.23% (47/194) | 0.48 | 0.008939 | 0.026593 |
GO:0071840 | cellular component organization or biogenesis | 3.09% (6/194) | 1.74 | 0.009436 | 0.027836 |
GO:0003779 | actin binding | 1.03% (2/194) | 3.65 | 0.010591 | 0.030985 |
GO:0016192 | vesicle-mediated transport | 2.06% (4/194) | 2.2 | 0.011175 | 0.032424 |
GO:0008612 | peptidyl-lysine modification to peptidyl-hypusine | 0.52% (1/194) | 6.11 | 0.014525 | 0.038954 |
GO:0005094 | Rho GDP-dissociation inhibitor activity | 0.52% (1/194) | 6.11 | 0.014525 | 0.038954 |
GO:0004814 | arginine-tRNA ligase activity | 0.52% (1/194) | 6.11 | 0.014525 | 0.038954 |
GO:0006420 | arginyl-tRNA aminoacylation | 0.52% (1/194) | 6.11 | 0.014525 | 0.038954 |
GO:0016538 | cyclin-dependent protein serine/threonine kinase regulator activity | 0.52% (1/194) | 6.11 | 0.014525 | 0.038954 |
GO:0019781 | NEDD8 activating enzyme activity | 0.52% (1/194) | 6.11 | 0.014525 | 0.038954 |
GO:0045116 | protein neddylation | 0.52% (1/194) | 6.11 | 0.014525 | 0.038954 |
GO:0006480 | N-terminal protein amino acid methylation | 0.52% (1/194) | 6.11 | 0.014525 | 0.038954 |
GO:0008097 | 5S rRNA binding | 0.52% (1/194) | 6.11 | 0.014525 | 0.038954 |
GO:0072546 | ER membrane protein complex | 0.52% (1/194) | 6.11 | 0.014525 | 0.038954 |
GO:0043412 | macromolecule modification | 4.64% (9/194) | 1.18 | 0.01836 | 0.048868 |